(Thanks Chuck!)
It’s a matter of philosophy
When it comes to developing prescription drugs at the pharmaceutical giant GlaxoSmithKline, biologists, chemists and even statisticians impose an obvious order on the process.
But when Gary Merrill needs someone who can really think a problem through — someone who can do the heavy lifting of analysis — he turns to his philosophers.